BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23994256)

  • 1. Chemokine and cytokine levels in osteoarthritis and rheumatoid arthritis synovial fluid.
    Hampel U; Sesselmann S; Iserovich P; Sel S; Paulsen F; Sack R
    J Immunol Methods; 2013 Oct; 396(1-2):134-9. PubMed ID: 23994256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF.
    DeForge LE; Loyet KM; Delarosa D; Chinn J; Zamanian F; Chuntharapai A; Lee J; Hass P; Wei N; Townsend MJ; Wang J; Wong WL
    J Immunol Methods; 2010 Oct; 362(1-2):70-81. PubMed ID: 20833179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis.
    Horiuchi T; Yoshida T; Koshihara Y; Sakamoto H; Kanai H; Yamamoto S; Ito H
    Endocr J; 1999 Oct; 46(5):643-9. PubMed ID: 10670749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
    Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
    Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies.
    de Jager W; Prakken BJ; Bijlsma JW; Kuis W; Rijkers GT
    J Immunol Methods; 2005 May; 300(1-2):124-35. PubMed ID: 15896801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.
    Brentano F; Schorr O; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2005 Sep; 52(9):2656-65. PubMed ID: 16142732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.
    Ishida S; Yamane S; Ochi T; Nakano S; Mori T; Juji T; Fukui N; Itoh T; Suzuki R
    J Rheumatol; 2008 Jun; 35(6):960-8. PubMed ID: 18412315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
    Kinloch A; Lundberg K; Wait R; Wegner N; Lim NH; Zendman AJ; Saxne T; Malmström V; Venables PJ
    Arthritis Rheum; 2008 Aug; 58(8):2287-95. PubMed ID: 18668562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
    Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
    J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
    Schlenk J; Lorenz HM; Haas JP; Herrmann M; Hohenberger G; Kalden JR; Röllinghoff M; Beuscher HU
    J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis.
    Hasegawa M; Nakoshi Y; Iino T; Sudo A; Segawa T; Maeda M; Yoshida T; Uchida A
    J Rheumatol; 2009 Feb; 36(2):240-5. PubMed ID: 19208558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
    Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.